The US Food and Drug Administration (FDA) is warning physicians that data from both clinical and industry sources suggests that the occurrence of Type III endoleaks in patients who have undergone ...

A lone endovascular graft system for use in EVAR procedures is responsible for the increased rates of Type III endoleaks that have been of concern to the US Food and Drug Administration (FDA) for the ...

Please provide your email address to receive an email when new articles are posted on . The FDA’s Circulatory System Devices Panel advised that for a stent graft system to treat patients with ...

SILVER SPRING, MD — There appears to have been an increase in type IIIa and IIIb endoleaks with endovascular graft systems used for endovascular aneurysm repair (EVAR), the US Food and Drug ...

Twenty-six case series and one comparative study were identified. The data extracted from 26 case series were for nonruptured TAA alone. In all studies combined, 1,038 patients underwent endovascular ...

Endovascular aneurysm repair is a minimally invasive technique for the treatment of abdominal aortic aneurysms—life-threatening bulges in the aorta's abdominal section. However, it carries the risk of ...